
Up to 10,000 Britons are set to take part in clinical trials for personalised cancer vaccines by 2030 after the Government signed an agreement with a leading pharmaceutical firm.
Patients will be given precision immunotherapies which work by stimulating the immune system to recognise and eliminate cancer cells.